Jessica Bodea, Kenneth J Caldwell & Sara M Federico from the Department of Oncology, St. Jude Children’s Research Hospital, Memphis and from the Johns Hopkins All Children’s Hospital, Cancer and Blood Disorders Institute, United States have just published a phase 2 trial to explore the activity of Bevacizumab, Sorafenib and Cyclophosphamide in bone sarcomas. The article entitled : Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory (...)